WOCKHARDT BIO AG FDA Approval ANDA 074703

ANDA 074703

WOCKHARDT BIO AG

FDA Drug Application

Application #074703

Documents

Letter2011-05-17
Review2011-12-02
Review2011-12-02
Letter2011-05-17
Medication Guide2011-02-18

Application Sponsors

ANDA 074703WOCKHARDT BIO AG

Marketing Status

Prescription001

Application Products

001SOLUTION;ORALEQ 5MG BASE/5ML0METOCLOPRAMIDE HYDROCHLORIDEMETOCLOPRAMIDE HYDROCHLORIDE

FDA Submissions

ORIG1AP1997-10-31
LABELING; LabelingSUPPL2AP2001-12-20
LABELING; LabelingSUPPL3AP2002-07-12
LABELING; LabelingSUPPL4AP2003-08-18
LABELING; LabelingSUPPL5AP2012-05-16
LABELING; LabelingSUPPL6AP2009-06-30
LABELING; LabelingSUPPL7AP2009-09-15
LABELING; LabelingSUPPL8AP2011-02-17
LABELING; LabelingSUPPL9AP2011-02-15
LABELING; LabelingSUPPL10AP2014-04-08

Submissions Property Types

SUPPL1Null0
SUPPL5Null15
SUPPL7Null7
SUPPL10Null8

TE Codes

001PrescriptionAA

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 74703
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.